Manulife (Manufacturers Life Insurance)
IOVA icon

Manulife (Manufacturers Life Insurance)’s Iovance Biotherapeutics IOVA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Buy
365,471
+134,028
+58% +$429K ﹤0.01% 1702
2025
Q4 		$637K Buy
231,443
+6,228
+3% +$14.4K ﹤0.01% 2059
2025
Q3 		$489K Sell
225,215
-48,771
-18% -$115K ﹤0.01% 2215
2025
Q2 		$471K Buy
273,986
+2,160
+0.8% +$5.38K ﹤0.01% 2205
2025
Q1 		$905K Sell
271,826
-7,801
-3% -$40.2K ﹤0.01% 1854
2024
Q4 		$2.07M Sell
279,627
-32,280
-10% -$299K ﹤0.01% 1543
2024
Q3 		$2.93M Sell
311,907
-23,606
-7% -$224K ﹤0.01% 1414
2024
Q2 		$2.69M Sell
335,513
-23,475
-7% -$252K ﹤0.01% 1406
2024
Q1 		$5.32M Buy
358,988
+94,017
+35% +$1.09M ﹤0.01% 1167
2023
Q4 		$2.15M Buy
264,971
+1,042
+0.4% +$5.45K ﹤0.01% 1448
2023
Q3 		$1.2M Buy
263,929
+43,077
+20% +$281K ﹤0.01% 1639
2023
Q2 		$1.55M Buy
220,852
+56,165
+34% +$402K ﹤0.01% 1483
2023
Q1 		$1.01M Buy
164,687
+1,440
+0.9% +$9.94K ﹤0.01% 1632
2022
Q4 		$1.03M Buy
163,247
+3,426
+2% +$26.7K ﹤0.01% 1594
2022
Q3 		$1.53M Sell
159,821
-1,379
-0.9% -$15.9K ﹤0.01% 1454
2022
Q2 		$1.76M Buy
161,200
+57,897
+56% +$759K ﹤0.01% 1445
2022
Q1 		$1.73M Buy
+103,303
New +$1.6M ﹤0.01% 1547
2020
Q2 		– Sell
-71,140
Closed -$2.13M – 2888
2020
Q1 		$2.13M Buy
71,140
+5,435
+8% +$144K ﹤0.01% 1290
2019
Q4 		$1.82M Sell
65,705
-2,158
-3% -$49.1K ﹤0.01% 1426
2019
Q3 		$1.22M Sell
67,863
-275
-0.4% -$6.08K ﹤0.01% 1557
2019
Q2 		$1.67M Buy
68,138
+1,517
+2% +$22.8K ﹤0.01% 1436
2019
Q1 		$633K Buy
66,621
+8,055
+14% +$78.2K ﹤0.01% 1951
2018
Q4 		$518K Buy
58,566
+6,440
+12% +$62.1K ﹤0.01% 1939
2018
Q3 		$586K Sell
52,126
-6,983
-12% -$99.1K ﹤0.01% 2167
2018
Q2 		$757K Buy
59,109
+6,449
+12% +$94.3K ﹤0.01% 2065
2018
Q1 		$890K Buy
52,660
+6,843
+15% +$104K ﹤0.01% 1924
2017
Q4 		$367K Buy
45,817
+5,110
+13% +$41K ﹤0.01% 2534
2017
Q3 		$316K Sell
40,707
-1,128
-3% -$7.14K ﹤0.01% 2612
2017
Q2 		$308K Sell
41,835
-3,031
-7% -$19.3K ﹤0.01% 2668
2017
Q1 		$334K Buy
44,866
+6,212
+16% +$45.5K ﹤0.01% 2469
2016
Q4 		$269K Buy
38,654
+3,954
+11% +$27.2K ﹤0.01% 2561
2016
Q3 		$286K Buy
34,700
+2,675
+8% +$22.6K ﹤0.01% 2486
2016
Q2 		$259K Buy
32,025
+1,487
+5% +$9.34K ﹤0.01% 2515
2016
Q1 		$147K Buy
30,538
+1,038
+4% +$5.68K ﹤0.01% 2825
2015
Q4 		$227 Buy
29,500
+962
+3% +$6.68K ﹤0.01% 2559
2015
Q3 		$165 Buy
28,538
+586
+2% +$4.56K ﹤0.01% 2801
2015
Q2 		$257 Buy
+27,952
New +$312K ﹤0.01% 2651

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s IOVA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Iovance Biotherapeutics (IOVA) stake by 58% in Q1 2026, buying an estimated $429K and bringing the position to 365,471 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1702.

Manulife (Manufacturers Life Insurance) first reported a position in IOVA in Q2 2015 and has held it in 37 quarters since. The position peaked at $5.32M in Q1 2024. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 365,471 shares of Iovance Biotherapeutics worth $1.28M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 134,028 Iovance Biotherapeutics shares in Q1 2026, an estimated $429K.
  • Iovance Biotherapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1702 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Iovance Biotherapeutics in Q2 2015 and has held it in 37 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Iovance Biotherapeutics position peaked at $5.32M in Q1 2024.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.